Loading...

VNRX VOLITIONRX LTD Delisting Actions 8-K Filing

VLTN

VNRX

VOLITIONRX LTD

(VNRX)

2026 8-K

Financial Results Update

Stock Split Approved

Listing Compliance Update

Stock Split Approved

Shareholder Meeting Results

Financial Results Announcement

Stock Issuances

Non-Compliance Notice

Funding Agreement Update

Management Change

Financial Results Update

Amended Underwriting Agreement

Offering Amendment

Stock Offering Update

Public Offering Details

Financial Results Announcement

Equity Offerings

Increase in authorized shares

Financial Statements

Share Sale Agreement

Stock Registration

Financial Results

Management Appointment

Director Appointment

Management Changes

Oncology Portfolio

Financial Results

Annual Meeting Approval and...

Earnings Reports

Financial Results and Busin...

Financing Round

Amendment to Stock Incentiv...

Agreement for Public Offering

External Links:

VolitionRx Ltd reported on April 23, 2026, that the NYSE American accepted its plan to regain compliance with stockholder equity requirements, allowing until August 6, 2027, to meet the standards after previously not complying. If the company does not comply by the deadline, it may face delisting proceedings.

AI Assistant

VOLITIONRX LTD

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.